Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer
Frontiers in Pharmacology · 04.12.2024 · 15
DOI: 10.3389/fphar.2024.1507042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 04.12.2024. Verfasst von Ziwei Fang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Healthcare Hospital, Bei…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS.
Abstract (Originalsprache)
Introduction
Endometrial cancer is the most common malignancy of the female reproductive system in the United States. Asparagus officinalis is a versatile, nutrient-dense, low-calorie vegetable that contains various bioactive metabolites that have shown a variety of biologic functions beneficial to health. The metabolites from asparagus officinalis extracts or asparagus officinalis extracts exhibit significant anti-tumorigenic activity in some pre-clinical models of cancer.
Methods
Endometrial cancer cells were used to study the effects of asparagus officinalis on anti-proliferation, anti-invasion and increased sensitivity to cisplatin, and obese and lean Lkb1 fl/fl p53 fl/fl mouse model of endometrial cancer was used to study the role of asparagus officinalis in tumor growth.
Results
Treatment with increasing concentrations of Asparagus officinalis extracts significantly inhibited cell proliferation, reduced glycolytic activity, induced cellular stress and apoptosis, caused cell cycle G1 arrest, increased the sensitivity of cells to cisplatin, reduced cell adhesion and invasion, and activation of AMPK and inhibition of the AKT/mTOR and MAPK signaling pathways in endometrial cancer cells. Moreover, asparagus officinalis extracts suppressed cell adhesion and invasion through the modulation of the epithelial-to-mesenchymal transition process. Asparagus officinalis extract treatment for 4 weeks resulted in a significant reduction in tumor growth in Lkb1 fl/fl p53 fl/fl mice under both obese and lean conditions, with a decrease in Ki-67 and vascular endothelial growth factor expression and an increase in Bip expression in endometrial tumors.
Discussion
These findings provide strong preclinical evidence for the potential therapeutic benefit of asparagus officinalis extract as a novel dietary strategy in the treatment of endometrial cancer. Further clinical trials of dietary intervention of asparagus officinalis or combination with cisplatin in patients with endometrial cancer are warranted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Healthcare Hospital, Beijing, China.
- Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
- Department of Gynecology, Shanghai University of Medicine and Health Sciences Affiliated Sixth People's Hospital South Campus, Shanghai, China.
- Shandong Juxinyuan Asparagus Industry Development Research Institute, HeZe, Shandong, China.
- Shandong Juxinyuan Agricultural Technology Co, LTD., HeZe, Shandong, China.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Förderung
- NIEHS NIH HHS
Zitieren
APA
Fang, Z., Kong, W., Zhao, Z., Sun, W., Xu, G., Clark, L. H., Sullivan, S. A., Tran, A. Q., Zhou, C. S., Sun, D., Zhao, L., Wang, J., Zhou, C., & Bae-Jump, V. L. (2024). Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1507042
Vancouver
Fang Z, Kong W, Zhao Z, Sun W, Xu G, Clark LH, et al. Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1507042
BibTeX
@article{Fang2024,
author = {Fang, Ziwei and Kong, Weimin and Zhao, Ziyi and Sun, Wenchuan and Xu, Guangxu and Clark, Leslie H and Sullivan, Stephanie A and Tran, Arthur-Quan and Zhou, Chang-Sheng and Sun, Delin and Zhao, Luyu and Wang, Jiandong and Zhou, Chunxiao and Bae-Jump, Victoria L},
title = {Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1507042}
}
EUVIMED